Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Multi

DKB Fonds - Pharma Fonds

+ Add to Watchlist

DKBPHAR:LX

62.20 EUR 0.09 0.14%

As of 10:47:44 ET on 01/27/2015.

Snapshot for DKB Fonds - Pharma Fonds (DKBPHAR)

Year To Date: +10.40% 3-Month: +18.34% 3-Year: +28.60% 52-Week Range: 42.16 - 62.29
1-Month: +10.09% 1-Year: +41.01% 5-Year: +19.72% Beta vs MSGUHC: 0.91

Mutual Fund Chart for DKBPHAR

No chart data available.
  • DKBPHAR:LX 62.20
  • 1M
  • 1Y
Interactive DKBPHAR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DKBPHAR

DKB Pharma Fonds is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term growth. The Fund invests in equities issued by pharmaceutical, technology and biotechnology companies in North America and Europe.

Inception Date: 11-22-1999 Telephone: 352-424345464
Managers: MARKUS HAMELLA
Web Site: www.bayerninvest.lu

Fundamentals for DKBPHAR

NAV (on 2015-01-27) 62.20
Assets (M) (on 2015-01-27) 43.25
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for DKBPHAR

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for DKBPHAR

Front Load 5.00
Back Load 0.00
Current Mgmt Fee 1.40
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.82

Top Fund Holdings for DKBPHAR

Filing Date: 12/31/2014
Name Position Value % of Total
Novartis AG 33,933 2,606,013 6.684%
Pfizer Inc 85,500 2,203,724 5.652%
Roche Holding AG 8,450 1,896,606 4.865%
Gilead Sciences Inc 19,100 1,494,688 3.834%
Merck & Co Inc 29,600 1,401,616 3.595%
Sanofi 17,000 1,275,000 3.270%
AbbVie Inc 22,500 1,225,277 3.143%
GlaxoSmithKline PLC 57,000 1,004,911 2.578%
AstraZeneca PLC 17,207 998,921 2.562%
UnitedHealth Group Inc 11,800 996,838 2.557%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil